GRML Market Analysis
Wall Street coverage
third-party contextWall Street coverage
$110.00median target· current $3.00 (+3572.8%)1 analyst
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
News & Sentiment
34 articles · sorted by datePage 1 of 2 · 34 total
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
Fundamentals
Updated daily after market closeP/E ratio—
EPS (TTM)$-6.600.0% YoY
Profit margin0.0%BASIC MATERIALS
Market cap$9.9MMicro cap
Valuation
- Forward P/E
- —
- PEG ratio
- —
- P/B
- 0.18
- P/S (TTM)
- —
- EV/EBITDA
- —
Profitability & growth
- ROE (TTM)
- -63.5%
- Operating margin
- 0.0%
- Revenue growth YoY
- 0.0%
- Dividend yield
- —
- Beta
- 2.48
Last earnings
Aug 17, 2026 · Reported $-0.03
Analyst estimate. Actual results often differ.
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
About Greenland Mines Ltd
Company profileGreenland Mines Ltd develops medicines for the treatment of cancer, cardiovascular, and neurodegenerative disorders. The company is headquartered in Omaha, Nebraska.
Classification
- Sector
- Basic Materials
- Industry
- Other Precious Metals & Mining
- Exchange
- NASDAQ
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 1300 SOUTH BOULEVARD, CHARLOTTE, NC
- Fiscal year end
- December
- Latest quarter
- Jun 30, 2026
Market cap$9.9M
Shares outstanding$3.2M
52W high$36.99
52W low$2.96
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer
Balanced Agent